Invention Grant
- Patent Title: Anti-dengue virus antibodies having cross-reactivity to Zika virus and methods of use
-
Application No.: US16980611Application Date: 2019-03-15
-
Publication No.: US11891432B2Publication Date: 2024-02-06
- Inventor: Katja Fink , Cheng-I Wang , Lisa Fong Poh Ng , Laurent Renia , Zenjiro Sampei , Xing'er Christine Xoo
- Applicant: Chugai Seiyaku Kabushiki Kaisha , Agency for Science, Technology & Research
- Applicant Address: JP Tokyo
- Assignee: Chugai Seiyaku Kabushiki Kaisha,Agency for Science, Technology & Research
- Current Assignee: Chugai Seiyaku Kabushiki Kaisha,Agency for Science, Technology & Research
- Current Assignee Address: JP Tokyo; SG Singapore
- Agency: Nixon & Vanderhye P.C.
- Priority: SG 201802164Y 2018.03.15
- International Application: PCT/SG2019/050145 2019.03.15
- International Announcement: WO2019/177543A 2019.09.19
- Date entered country: 2020-09-14
- Main IPC: C07K16/10
- IPC: C07K16/10 ; A61P31/14 ; A61K39/00
Abstract:
The disclosure provides anti-DENV antibodies having a cross-reactivity to ZIKV and methods of making and using the same. The anti-DENV antibodies have uses that include treating or preventing ZIKV infection.
Public/Granted literature
- US20210017256A1 ANTI-DENGUE VIRUS ANTIBODIES HAVING CROSS-REACTIVITY TO ZIKA VIRUS AND METHODS OF USE Public/Granted day:2021-01-21
Information query
